Novo Holdings

Novo Holdings

Novo Holdings

$80,000,000 Venture capital
FinSMEs

Milestone Pharmaceuticals Raises $80M in Equity Funding

Funding Health
$80,000,000 Venture capital (Series B)
FinSMEs

Morphic Therapeutic Raises $80M in Series B Financing

Funding Health
$60,000,000 Venture capital (Series B)
FinSMEs

Biotech Company Therachon Raises $60M Mezzanine Financing

Funding Health
$5,000,000 Venture capital (Series A)
Therachon

Therachon Appoints Luca Santarelli, M.D., as Chief Executive Officer and Extends Series A Financing

$35,000,000 Venture capital (Series A)
businesswire

Therachon Secures $35 Million Financing | Business Wire